Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Aldeyra Therapeutics, Inc. (ALDX)

« Back to company index

ALDX Chatter Timeline

Stock Ticker for ALDX

Most Active Tweeters for ALDX

UserTweets
@fezziwig2008 30
@SleekMoneycom 2
@stocknewstimes 2
@AlexandriaCairo 2
@AmericanBanking 2

Recent Tweets for ALDX

fezziwig2008 @fezziwig2008
@TheHunter5515 Some more future competition in autoimmune disease in smokers from $ALDX #Aldehyde trap going system… https://t.co/SdI1EjJ1f7
May 22nd 2019, 3:05pm
fezziwig2008 @fezziwig2008
$ALDX in Sjogren’s Syndrome https://t.co/FAZGohDkDr
May 22nd 2019, 12:05pm
AlexandriaCairo @AlexandriaCairo
RT @fezziwig2008: $BHC #1 Allergic Conjunctivitis Rx Bepreve going generic- approved March 2019 - https://t.co/65ZOGhDRPX $ALDX Reproxalap…
May 22nd 2019, 11:05am
fezziwig2008 @fezziwig2008
$BHC #1 Allergic Conjunctivitis Rx Bepreve going generic- approved March 2019 - https://t.co/65ZOGhDRPX $ALDX Repr… https://t.co/JFCC2y5Nwl
May 22nd 2019, 9:05am
bulletin_en @bulletin_en
Seelos Therapeutics Inc. $ALDX Comparing side by side https://t.co/ugDPjgWx5U
May 21st 2019, 6:05pm
stb8444 @stb8444
added $aldx, removed $vcel
May 20th 2019, 7:05pm
fezziwig2008 @fezziwig2008
@renaud_glen Uveitis P3 reads out positive [email protected] - along side AC- $ALDX stays up - because DED has strongest data
May 17th 2019, 2:05pm
fezziwig2008 @fezziwig2008
$ALDX ADX-629 Systemic Rx targeting autoimmunity https://t.co/utawS567op
May 17th 2019, 1:05pm
AlexandriaCairo @AlexandriaCairo
RT @fezziwig2008: In an ongoing effort to explain such significant p values in P2b Dry Eye data presented @ARVO - $ALDX qualified the resul…
May 17th 2019, 11:05am
fezziwig2008 @fezziwig2008
In an ongoing effort to explain such significant p values in P2b Dry Eye data presented @ARVO - $ALDX qualified the… https://t.co/2M2Kcl9hk1
May 17th 2019, 7:05am
AmpBioResearch @AmpBioResearch
$ALDX ARVO reproxalap data from 5/1. Slides still say "p values subject to change based on quality control analysis… https://t.co/uvywXLa3Fj
May 16th 2019, 7:05pm
Nonfiction8879 @Nonfiction8879
@4thQuarterCap Loaded it.. first time position ... 35,000 shares ... will continue under to under 7.50. $aldx
May 16th 2019, 7:05pm
4thQuarterCap @4thQuarterCap
Added to $ALDX https://t.co/hIZiW15iK8
May 16th 2019, 6:05pm
Aesculapius1898 @Aesculapius1898
RT @fezziwig2008: U of Chicago still needs to do its 1st DNAase Randomized Clinical Trial - $ALDX is now enrolling P3 - before doing PR on…
May 16th 2019, 6:05pm
fezziwig2008 @fezziwig2008
Aciont is a steroid, Eyegate is a Rube Goldberg Contraption - but $ALDX is an effective safe nonsteroidal drop that… https://t.co/Hb8XqhnkpY
May 16th 2019, 3:05pm
renaud_glen @renaud_glen
Would you expect a buyer to show up AFTER the P3 data, or coudl they show up sooner? $aldx
May 16th 2019, 3:05pm
fezziwig2008 @fezziwig2008
@TC22108313 I absolutely spoke to -#Appaloosa’s Owner @DavidTepper5 on his cell. - I can tell you $ALDX is in the c… https://t.co/vI5V7S8db3
May 16th 2019, 3:05pm
fezziwig2008 @fezziwig2008
Systemic $ALDX will be funded by Dry Eye, Allergic Conjunctivitis and Uveitis drops - and will out earn them all.… https://t.co/2uz1ogTaQG
May 16th 2019, 2:05pm
fezziwig2008 @fezziwig2008
U of Chicago still needs to do its 1st DNAase Randomized Clinical Trial - $ALDX is now enrolling P3 - before doing… https://t.co/RZRacg4GI5
May 16th 2019, 12:05pm
RSIDayTrader @RSIDayTrader
@fezziwig2008 you sold out?? didn't u have 70k shares or something $ALDX
May 16th 2019, 12:05pm
SelfThink4 @SelfThink4
$ACRX $ALDX weakness among strong start for most bios.
May 16th 2019, 9:05am
fezziwig2008 @fezziwig2008
RT @fezziwig2008: South Korean Pharma targeting DED market $AGN $ALDX https://t.co/lu303HgsHg
May 15th 2019, 2:05pm
fezziwig2008 @fezziwig2008
RT @fezziwig2008: $AGN @brentlsaunders may be cheap and take out Korean cyclosporine knockoff $ALDX
May 15th 2019, 1:05pm
fezziwig2008 @fezziwig2008
$AGN @brentlsaunders may be cheap and take out Korean cyclosporine knockoff $ALDX
May 15th 2019, 12:05pm
fezziwig2008 @fezziwig2008
Korean $AGN “Replasis” https://t.co/lu303HgsHg $ALDX competition
May 15th 2019, 11:05am
fezziwig2008 @fezziwig2008
South Korean Pharma targeting DED market $AGN $ALDX https://t.co/lu303HgsHg
May 15th 2019, 11:05am
fezziwig2008 @fezziwig2008
Obviously I’m long (very) $HALO and $ALDX but solely because I can’t find any Science for Sale thats’s Better - I L… https://t.co/XTK0grVOaO
May 14th 2019, 8:05am
macondailynews @macondailynews
Aldeyra Therapeutics $ALDX Receives “Buy” Rating from Canaccord Genuity https://t.co/wWl50BcTrk
May 14th 2019, 5:05am
fezziwig2008 @fezziwig2008
RT @DeepSouthDoctor: Buying $ALDX. Sold this at over $14 in September (my best buy of 2018), happy to buy back at these levels w all of the…
May 13th 2019, 3:05pm
fezziwig2008 @fezziwig2008
RT @fezziwig2008: Poker’s Going Up for Dry Eye Drops via $NVS - $ALDX value rose considerably yesterday (long) https://t.co/w7agiZNK5f
May 13th 2019, 3:05pm
DeepSouthDoctor @DeepSouthDoctor
Buying $ALDX. Sold this at over $14 in September (my best buy of 2018), happy to buy back at these levels w all of… https://t.co/WLO3BKzKIr
May 13th 2019, 1:05pm
DeepSouthDoctor @DeepSouthDoctor
SMID biotechs w attractive valuations and key data catalysts this year for whose trials I am bullish: $ALDX $AUPH… https://t.co/JEOcLfdF08
May 13th 2019, 10:05am
fezziwig2008 @fezziwig2008
Antiinflammatory Mechanism of Action of $ALDX trapping aldehydes is in limiting cytokine release… https://t.co/puWYrsogu4
May 13th 2019, 7:05am
DataTrials @DataTrials
$ALDX Phase 3 SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.… Estimated Primary Completion Date - 06/2019
May 12th 2019, 9:05pm
registrarjourn @registrarjourn
Aldeyra Therapeutics $ALDX Rating Reiterated by Canaccord Genuity https://t.co/Q4IP5BwMsZ
May 12th 2019, 11:05am
EnterpriseLeade @EnterpriseLeade
Aldeyra Therapeutics $ALDX Rating Reiterated by Canaccord Genuity https://t.co/UO1LcRB780
May 12th 2019, 11:05am
WeekHerald @WeekHerald
Aldeyra Therapeutics $ALDX Downgraded to “Sell” at Zacks Investment Research https://t.co/i2ZydTbjhm
May 12th 2019, 10:05am
ThisLincolnian @ThisLincolnian
Aldeyra Therapeutics $ALDX Downgraded to “Sell” at Zacks Investment Research https://t.co/zpHvEU9k5P
May 12th 2019, 10:05am
fezziwig2008 @fezziwig2008
@zbiotech Spoke Briefly with @DavidTepper5 about $AGN purchase of $ALDX 2wks ago - no response from his #Biotech An… https://t.co/GYuaGS2gkA
May 11th 2019, 4:05pm
fezziwig2008 @fezziwig2008
@zbiotech $AGN will buy $ALDX - #KitAndCaboodle
May 11th 2019, 3:05pm
stocknewstimes @stocknewstimes
Canaccord Genuity Reiterates Buy Rating for Aldeyra Therapeutics $ALDX https://t.co/8xUhCuUMv7
May 11th 2019, 2:05pm
SleekMoneycom @SleekMoneycom
Canaccord Genuity Reiterates Buy Rating for Aldeyra Therapeutics $ALDX https://t.co/DchDIN6gYP #investing
May 11th 2019, 2:05pm
stocknewstimes @stocknewstimes
Aldeyra Therapeutics $ALDX Posts Earnings Results, Beats Expectations By $0.02 EPS https://t.co/XVQYUOjDCT
May 11th 2019, 11:05am
SleekMoneycom @SleekMoneycom
Aldeyra Therapeutics $ALDX Posts Earnings Results, Beats Expectations By $0.02 EPS https://t.co/j5X7A9d98Q #investing
May 11th 2019, 11:05am
fezziwig2008 @fezziwig2008
@bradloncar Yes $ALDX has 5 positive P2a,bs - the only one negative- in Allergic Conjunctivitis - was positive rece… https://t.co/igxwNQRC09
May 11th 2019, 2:05am
Stock_News_Now @Stock_News_Now
$ALDX: New SEC Filing for ALDX: Form 10-Q (No. 0001564590-19-018542): https://t.co/VTWX1zHii3
May 10th 2019, 4:05pm
fezziwig2008 @fezziwig2008
Just added $ALDX @ 7.69 @TraderSilver1 - if you’re not buying, you’re missing a great opportunity. But we can’t all be Ophthalmologists.
May 10th 2019, 3:05pm
fezziwig2008 @fezziwig2008
$ALDX $213M Company with (1) positive P3 and (5) positive P2’s - so compelling I’m kvelling.
May 10th 2019, 1:05pm
AmericanBanking @AmericanBanking
Aldeyra Therapeutics $ALDX Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS https://t.co/Nj01tHTJao #stocks
May 10th 2019, 1:05pm
ThisLincolnian @ThisLincolnian
Aldeyra Therapeutics $ALDX Releases Earnings Results, Beats Expectations By $0.02 EPS https://t.co/O6yTVszeMZ
May 10th 2019, 1:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.